Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Multiple sclerosis: oral drugs].
Anxiety state affects information processing speed in patients with multiple sclerosis.
Olfactory dysfunction in patients with neuromyelitis optica.
Novartis provides update on fingolimod Phase III trial in primary progressive MS (PPMS)
Multiple Roles for Nogo Receptor 1 in Visual System Plasticity.
Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation.
Altered functional connectivity and performance variability in relapsing-remitting multiple sclerosis.
Abnormal myelin and axonal integrity in recently diagnosed patients with obstructive sleep apnea.
Assessment of prevalence and pathological response to orthostatic provocation in patients with multiple sclerosis.
Bradykinin type 2 receptor -9/-9 genotype is associated with triceps brachii muscle hypertrophy following strength training in young healthy men.
Induction of heat shock protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun.
Ureteral rupture from aberrant Foley catheter placement: A case report.
Errors in the Byline, Author Affiliations, and Author Contributions in: Long-term Follow-up of Acute Partial Transverse Myelitis.
[Does the Medical Doctor's Pension Fund diagnose multiple sclerosis correct?].
Acquired Demyelinating and Other Autoimmune Disorders of the Central Nervous System in Children.
[The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].
The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas.
Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.
Leukotrienes induce the migration of Th17 cells.
Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data.
Combined central and peripheral demyelination: A case description.
Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis?
Nationwide Incidence of Acquired Central Nervous System Demyelination in Icelandic Children.
AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities.
Pages
« first
‹ previous
…
560
561
562
563
564
565
566
567
568
…
next ›
last »